Related Experiment Video
Updated: Feb 18, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas
Vedran Kardum1, Valentina Karin2, Mislav Glibo2
1Department of Obstetrics and Gynecology, University Hospital Merkur, Zagreb, Croatia.
Abstract:
Wnt is a highly conserved signaling pathway responsible for tissue regeneration, maintenance and differentiation of stem cells in adults. Its aberrant activation through reduced expression of Wnt signaling pathway inhibitors, such as proteins from the SFRP family, is commonly seen in many tumors. In the present study we explored SFRP1 protein expression using immunohistochemistry in 11 low-grade serous ovarian carcinomas (LGSC), 42 high-grade serous ovarian carcinomas (HGSC), and 5 normal ovarian tissues (controls). SFRP1 gene methylation was analyzed by methylation-specific PCR in 8 LGSCs, 13 HGSCs and control samples. SFRP1 gene was unmethylated and SFRP1 protein expression was strong in normal ovaries (n=5). Although SFRP1 gene was unmethylated in almost all of the LGSC cases (7/8, 88%), SFRP1 protein expression was significantly lower than in normal ovaries (p<0.05). Seven out of 13 HGSCs (54%) showed SFRP1 gene hypermethylation and protein expression level was also significantly lower than in normal ovaries (p<0.001). Our preliminary data show loss of SFRP1 protein expression caused by the SFRP1 promoter hypermethylation in a subset of HGSCs. SFRP1 protein expression was also lost in LGSCs but different regulatory mechanisms may be involved. Further studies should elucidate the clinical and therapeutic relevance of the observed molecular alterations.
Insights
Secreted frizzled-related protein 1 (SFRP1) loss is observed in ovarian cancers. While SFRP1 is unmethylated in low-grade serous ovarian carcinomas (LGSC), its expression is reduced. High-grade serous ovarian carcinomas (HGSC) show SFRP1 hypermethylation and reduced expression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Wnt signaling pathway is crucial for tissue regeneration and stem cell regulation.
- Aberrant Wnt pathway activation, often due to reduced expression of inhibitors like SFRP1, is implicated in tumorigenesis.
- SFRP1 acts as a Wnt antagonist, and its dysregulation is observed in various cancers.
Purpose of the Study:
- To investigate the expression of SFRP1 protein in different grades of ovarian carcinoma.
- To analyze the methylation status of the SFRP1 gene in ovarian cancer tissues.
- To explore the correlation between SFRP1 expression, gene methylation, and ovarian cancer subtypes.
Main Methods:
- Immunohistochemistry was used to assess SFRP1 protein expression in normal ovarian tissues, LGSC, and HGSC.
- Methylation-specific PCR was employed to analyze SFRP1 gene promoter methylation.
- Statistical analysis was performed to compare SFRP1 expression levels between groups.
Main Results:
- SFRP1 gene was unmethylated and protein expression was strong in normal ovarian tissues.
- SFRP1 gene was largely unmethylated in LGSC, but protein expression was significantly lower than in normal controls.
- HGSC samples showed SFRP1 gene hypermethylation in 54% of cases, with significantly reduced protein expression compared to normal ovaries.
Conclusions:
- Loss of SFRP1 protein expression occurs in both LGSC and HGSC, suggesting its role in ovarian tumorigenesis.
- SFRP1 promoter hypermethylation is a mechanism contributing to SFRP1 loss in a subset of HGSCs.
- Further research is needed to understand the regulatory mechanisms in LGSC and the clinical/therapeutic implications of SFRP1 alterations in ovarian cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

